{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:05Z","timestamp":1787321045491,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW111-TDU-B-221-014005"],"award-info":[{"award-number":["MOHW111-TDU-B-221-014005"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11102061"],"award-info":[{"award-number":["NCKUH-11102061"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2634-F-006-002 and MOST 111-2634-F-006-007"],"award-info":[{"award-number":["MOST 111-2634-F-006-002 and MOST 111-2634-F-006-007"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Limited efficacy has been observed when using opioids to treat neuropathic pain. Lidocaine patches reduce neuropathic pain in postherpetic neuralgia, but their benefits for cancer-related neuropathic pain remain unclear. This study aimed to investigate a treatment for cancer-related neuropathic pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective, open-label, single-arm study to assess the efficacy and safety of lidocaine transdermal patches in patients experiencing localized, superficial, neuropathic cancer pain. Terminal cancer patients already receiving opioid treatment participated in the 3-day study. The primary endpoint was pain intensity evaluated by the numerical rating scale (NRS). The secondary endpoints were the pain relief score and the quality of analgesic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed a significant difference in the median NRS over 3 days (Kruskal\u2013Wallis test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The median NRS pain intensity from Day 1 to Day 3 was 4.0 with 95% C.I. (3.3, 5.0), 3.0 (2.5, 3.5), and 2.6 (2.0, 3.0), respectively. The difference between the median NRS pain intensities of any 2 days was significant (Wilcoxon signed-rank test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The generalized estimating equation (GEE) estimation model showed significant differences between the NRS pain intensities on any 2 days. There was no significant difference in the pain relief score or the quality of analgesic treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, the 5% lidocaine transdermal patch reduced the NRS pain intensity in neuropathic cancer patients already receiving opioid treatment. Treatment of localized and superficial neuropathic pain caused by cancer was well tolerated and effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-023-01126-3","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T23:26:39Z","timestamp":1673047599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment"],"prefix":"10.1186","volume":"22","author":[{"given":"Jui-Hung","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Tzu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-Lin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yeh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"issue":"3","key":"1126_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00002508-200009000-00005","volume":"16","author":"A Devers","year":"2000","unstructured":"Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain. 2000;16(3):205\u20138. https:\/\/doi.org\/10.1097\/00002508-200009000-00005.","journal-title":"Clin J Pain"},{"issue":"6","key":"1126_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jpainsymman.2015.12.336","volume":"51","author":"A Roberto","year":"2016","unstructured":"Roberto A, Deandrea S, Greco MT, et al. Prevalence of neuropathic pain in Cancer patients: pooled estimates from a systematic review of published literature and results from a survey conducted in 50 Italian palliative care centers. J Pain Symptom Manag. 2016;51(6):1091\u20131102.e4. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.336.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"1126_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bja\/aet208","volume":"111","author":"MT Fallon","year":"2013","unstructured":"Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013;111(1):105\u201311. https:\/\/doi.org\/10.1093\/bja\/aet208.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1126_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/cancers11030373","volume":"11","author":"HL Edwards","year":"2019","unstructured":"Edwards HL, Mulvey MR, Bennett MI. Cancer-related neuropathic pain. Cancers (Basel). 2019;11(3):373. https:\/\/doi.org\/10.3390\/cancers11030373.","journal-title":"Cancers (Basel)"},{"key":"1126_CR5","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002. https:\/\/doi.org\/10.1038\/nrdp.2017.2.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1126_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0885-3924(97)00009-2","volume":"14","author":"LA Martin","year":"1997","unstructured":"Martin LA, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manag. 1997;14(2):99\u2013117. https:\/\/doi.org\/10.1016\/s0885-3924(97)00009-2.","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"1126_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2165\/00003495-200464090-00002","volume":"64","author":"PS Davies","year":"2004","unstructured":"Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs. 2004;64(9):937\u201347. https:\/\/doi.org\/10.2165\/00003495-200464090-00002.","journal-title":"Drugs."},{"issue":"6","key":"1126_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/jps.2600830604","volume":"83","author":"P Singh","year":"1994","unstructured":"Singh P, Roberts MS. Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. J Pharm Sci. 1994;83(6):774\u201382. https:\/\/doi.org\/10.1002\/jps.2600830604.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1126_CR9","first-page":"181","volume":"47","author":"V Demarin","year":"2008","unstructured":"Demarin V, Basi\u0107-Kes V, Zavoreo I, et al. Recommendations for neuropathic pain treatment. Acta Clin Croat. 2008;47(3):181\u201391.","journal-title":"Acta Clin Croat"},{"issue":"5","key":"1126_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1155\/2009\/723179","volume":"14","author":"JA Fleming","year":"2009","unstructured":"Fleming JA, O'Connor BD. Use of lidocaine patches for neuropathic pain in a comprehensive cancer Centre. Pain Res Manag. 2009;14(5):381\u20138. https:\/\/doi.org\/10.1155\/2009\/723179.","journal-title":"Pain Res Manag"},{"issue":"4","key":"1126_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis. 1978;37(4):378\u201381. https:\/\/doi.org\/10.1136\/ard.37.4.378.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1126_CR12","first-page":"133","volume":"64","author":"SA Flaherty","year":"1996","unstructured":"Flaherty SA. Pain measurement tools for clinical practice and research. AANA J. 1996;64(2):133\u201340.","journal-title":"AANA J"},{"issue":"1","key":"1126_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11916-009-0009-x","volume":"13","author":"J Younger","year":"2009","unstructured":"Younger J, McCue R, Mackey S. Pain outcomes: a brief review of instruments and techniques. Curr Pain Headache Rep. 2009;13(1):39\u201343. https:\/\/doi.org\/10.1007\/s11916-009-0009-x.","journal-title":"Curr Pain Headache Rep"},{"issue":"1\u20132","key":"1126_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0304-3959(00)00482-6","volume":"92","author":"M Bennett","year":"2001","unstructured":"Bennett M. The LANSS pain scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92(1\u20132):147\u201357. https:\/\/doi.org\/10.1016\/s0304-3959(00)00482-6.","journal-title":"Pain."},{"issue":"2","key":"1126_CR15","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"},{"issue":"5","key":"1126_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11096-015-0094-3","volume":"37","author":"AD Masman","year":"2015","unstructured":"Masman AD, van Dijk M, Tibboel D, Baar FP, Math\u00f4t RA. Medication use during end-of-life care in a palliative care Centre. Int J Clin Pharm. 2015;37(5):767\u201375. https:\/\/doi.org\/10.1007\/s11096-015-0094-3.","journal-title":"Int J Clin Pharm"},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CPAA.S9795","volume":"2","author":"G Hans","year":"2010","unstructured":"Hans G, Robert D, Verhulst J, Vercauteren M. Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician. Clin Pharmacol. 2010;2:65\u201370. https:\/\/doi.org\/10.2147\/CPAA.S9795.","journal-title":"Clin Pharmacol"},{"issue":"1\u20132","key":"1126_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0304-3959(03)00317-8","volume":"106","author":"T Meier","year":"2003","unstructured":"Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106(1\u20132):151\u20138. https:\/\/doi.org\/10.1016\/s0304-3959(03)00317-8.","journal-title":"Pain."},{"issue":"7","key":"1126_CR19","doi-asserted-by":"publisher","first-page":"CD010958","DOI":"10.1002\/14651858.CD010958.pub2","volume":"2014","author":"S Derry","year":"2014","unstructured":"Derry S, Wiffen PJ, Moore RA, Quinlan J. Topical lidocaine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;2014(7):CD010958. https:\/\/doi.org\/10.1002\/14651858.CD010958.pub2 Published 2014 Jul 24.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-023-01126-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-023-01126-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-023-01126-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T10:09:52Z","timestamp":1673345392000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-023-01126-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1186\/s12904-023-01126-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1362676\/v1","asserted-by":"object"}]},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of NCKUH (BR-100-005-C) and conducted in accordance with the Declaration of Helsinki.All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}